Why economic leverage beats military pressure on Greenland, and how Denmark’s exposure through Novo Nordisk makes trade tools ...

Shares in Denmark's global healthcare company, Novo Nordisk jumped sharply on Friday after the U.K.'s regulator signed off on ...

Novo Nordisk ( NVO +1.68%) was once the top player in the weight loss drug market. The company's medicine, Wegovy, ...

Oral weight-loss drugs could account for a third or more of the overall GLP-1 market by 2030, a Novo Nordisk executive said ...

The funding aims to encourage innovation in Europe amid concerns that innovation across the continent is lagging behind China ...

Novo Nordisk Foundation grants DKK 5.5 billion to elevate innovation in Denmark and Europe ...

Novo Nordisk's Wegovy weight-loss pill has made an "encouraging" start after its launch this month, analysts said on Friday ...

The Novo Nordisk Foundation has allocated up to DKK 5.5 billion (EUR 736 million) to BioInnovation Institute (BII), a leading ...

The Novo Nordisk Foundation’s funds will go toward supporting early-stage companies working in “human health, planetary ...

LONDON, Jan 16 () - Novo Nordisk's Wegovy ​pill hit 3,071 ‌U. prescriptions in the first ‌four days after its launch, IQVIA ...

With attention in biotech focused on the JPM Healthcare conference in the US, the Novo Nordisk Foundation (NNF) has flown the ...

With 130+ startups launched and over €938 million in follow-on funding, BII’s Venture Lab, Bio Studio, and Quantum Lab scale ...